<DOC>
	<DOCNO>NCT00738400</DOCNO>
	<brief_summary>This control , randomize , multi-center prospective study vardenafil determine efficacy Erectile Dysfunction ( ED ) , tolerability safety men ED Metabolic Syndrome . This study explore rate patient need switch high dosage base upon expectation men stay vardenafil 10 mg PRN ( pro nata )</brief_summary>
	<brief_title>Study Vardenafil Patients Suffering From Erectile Dysfunction Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Stable heterosexual relationship History erectile dysfunction least 6 month IIEF EF Domain entry score ( Visit 2 ) : &gt; 21 point Documented metabolic syndrome accord IDF ( International Diabetes Foundation ) Subjects motivate erectile dysfunction treatment Documented , date , write informed consent Any underlying cardiovascular condition History myocardial infarction Uncontrolled atrial fibrillation Resting hypotension Postural hypotension within 6 month Visit 1 History congenital QT prolongation Bleeding disorder History prostatectomy prostate cancer Hereditary degenerative retinal disorder History loss vision NAION ( nonarteritic anterior ischemic optic neuropathy ) 29 Additional Exclusion Criteria</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Vardenafil</keyword>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Double-blind study</keyword>
</DOC>